World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
56637
World Ranking
5686
National Ranking
125

Overview

Yoshiya Tanaka is affiliated with the University of Occupational and Environmental Health Japan in Japan. Their research primarily focuses on the field of Medicine, with extensive contributions to subfields such as Rheumatology, Immunology, Genetics, Hematology, and Pathology and Forensic Medicine.

Their recent peer-reviewed publications include the following:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023, published in Annals of the Rheumatic Diseases
  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, published in The Lancet Respiratory Medicine
  • Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach, 2022, published in Nature Reviews Rheumatology
  • Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis, 2022, published in Nature Genetics
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement, 2020, published in Annals of the Rheumatic Diseases

Tanaka's work covers a range of main topics, including:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Autoimmune and Inflammatory Disorders Research
  • Monoclonal and Polyclonal Antibodies Research
  • Lymphoma Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions

The scientist has collaborated frequently with several co-authors, among them:

  • Tsutomu Takeuchi (119 collaborations)
  • Shingo Nakayamada (114 collaborations)
  • Satoshi Kubo (56 collaborations)
  • Yusuke Miyazaki (52 collaborations)
  • Yosuke Okada (51 collaborations)

Regarding publication venues, Tanaka has contributed numerous articles to:

  • Annals of the Rheumatic Diseases (83 publications)
  • Modern Rheumatology (67 publications)
  • Lara D. Veeken (59 publications)
  • Rheumatology and Therapy (33 publications)
  • RMD Open (31 publications)

Best Publications

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus

    Eric F Morand;Richard Furie;Yoshiya Tanaka;Ian N Bruce

  • T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

    Yoshiya Tanaka;David H. Adams;Stefan Hubscher;Hiroyuki Hirano

  • A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Lymphocyte interactions with endothelial cells.

    Yoji Shimizu;Walter Newman;Yoshiya Tanaka;Stephen Shaw

  • Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

    Peter C. Taylor;Edward C. Keystone;Désirée van der Heijde;Michael E. Weinblatt

  • Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

    Désirée van der Heijde;Yoshiya Tanaka;Roy Fleischmann;Edward Keystone

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

    Daniel J Wallace;Richard A Furie;Yoshiya Tanaka;Kenneth C Kalunian

  • Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes

    Yoshiya Tanaka;David H. Adams;Stephen Shaw

  • Janus kinase inhibitors in autoimmune diseases

    John J O'Shea;Apostolos Kontzias;Kunihiro Yamaoka;Yoshiya Tanaka

  • Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

    Tsutomu Takeuchi;Y. Tatsuki;Y. Nogami;N. Ishiguro

  • Osteoblasts and Osteoclasts in Bone Remodeling and Inflammation

    Yoshiya Tanaka;Shingo Nakayamada;Yosuke Okada

  • CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.

    Y Tanaka;S M Albelda;K J Horgan;G A van Seventer

  • Efficacy of rituximab (Anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

    Mikiko Tokunaga;Kazuyoshi Saito;Daisuke Kawabata;Yoshitaka Imura

  • Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

    Stanley B. Cohen;Yoshiya Tanaka;Xavier Mariette;Jeffrey R. Curtis

  • Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.

    G A van Seventer;W Newman;Y Shimizu;T B Nutman

  • Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

    Yasuo Suzuki;Hajime Nawata;Satoshi Soen;Saeko Fujiwara

  • Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

    Yoshikazu Nakaoka;Mitsuaki Isobe;Syuji Takei;Yoshiya Tanaka

Frequent Co-Authors

Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Hisashi Yamanaka
Hisashi Yamanaka International University of Health and Welfare
Takao Koike
Takao Koike Hokkaido University
Naoki Ishiguro
Naoki Ishiguro Nagoya University
Nobuyuki Miyasaka
Nobuyuki Miyasaka Tokyo Medical and Dental University
Tsuneyo Mimori
Tsuneyo Mimori Kyoto University
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Takayuki Sumida
Takayuki Sumida University of Tsukuba
Atsushi Kawakami
Atsushi Kawakami Nagasaki University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative or supplementary healthcare pathways? Online nursing degrees offer flexibility and affordability, making them an attractive option. For example, students can explore the cheapest fnp programs online to become advanced practice nurses without breaking the bank.

Cost is a major consideration for many. If you’re wondering how much is online nursing school, top programs now provide competitive tuition rates and various financial aid opportunities.

Ambitious nurses seeking advanced leadership or teaching roles can pursue doctorate in nursing education online programs, opening doors to academic and research careers.

Registered nurses looking for career advancement often choose to complete a bachelor’s degree through the cheapest rn to bsn program, enhancing their skills and job prospects.

Whether starting your journey or advancing your expertise, these affordable online pathways can fast-track your career in healthcare.

Best Scientists Citing Yoshiya Tanaka

Trending Scientists

Recently Published Articles